Dr. Carey Gleason’s research on hormone therapy’s effect on dementia risk highlighted in news outlets

Prior to a 2003 study, scientists believed estrogen therapy was protective for both the brain and the heart. The results of the 2003 study, the Women’s Health Initiative Memory study, however, suggested that women were at increased risk for dementia if they participated in estrogen therapy. This led to questions in the medical field regarding the use of menopausal hormone replacement therapy.

This led Dr. Carey Gleason to review three studies, one of which she and her team conducted. Through this review, Dr. Gleason found no cognitive harm as a result of menopausal hormone replacement therapy in younger women, although there may be negative effects for those who start hormone replacement therapy in their 70s and those with diabetes.

Gleason will also help coordinate a study this fall looking at cognition, mood, and amyloid in around 500 women who were involved in the studies conducted since the 2002 Women’s Health Initiative study. “More answers are coming,” Gleason said.

UW Study: Hormone Replacement Therapy Doesn't Increase Risk Of Alzheimer's Disease” was posted on Monday, July 23, 2018 to wpr.org. 

Hormone therapy at menopause doesn’t increase Alzheimer’s risk, UW research says” was posted on Monday, July 23, 2018 to the Wisconsin State Journal website. 

Women bear Alzheimer’s burden; researchers are trying to discover why” was posted on Monday, July 23, 2018 to cnn.com.